MAM
MRNA icon

Myriad Asset Management’s Moderna MRNA Stock Holding History

Myriad Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,041
Closed -$1.17M – 169
2021
Q3 		$1.17M Sell
3,041
-300,000
-99% -$111M 0.12% 99
2021
Q2 		$71.2M Hold
303,041
– – 5.31% 5
2021
Q1 		$39.7M Buy
303,041
+149,000
+97% +$21.6M 4.12% 6
2020
Q4 		$16.1M Hold
154,041
– – 3.3% 7
2020
Q3 		$10.9M Sell
154,041
-351,114
-70% -$24.5M 2.37% 12
2020
Q2 		$32.4M Buy
+505,155
New +$27.7M 6.01% 5
2019
Q1 		– Sell
-190,943
Closed -$2.92M – 99
2018
Q4 		$2.92M Buy
+190,943
New +$3.14M 0.62% 43

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Myriad Asset Management's MRNA Position: Q4 2021 in Review

Myriad Asset Management sold out of Moderna (MRNA) in Q4 2021, closing a stake of 3,041 shares — an estimated $1.17M sold.

Myriad Asset Management first reported a position in MRNA in Q4 2018 and held it in 7 quarters. The position peaked at $71.2M in Q2 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Myriad Asset Management reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Myriad Asset Management sold 3,041 Moderna shares in Q4 2021, an estimated $1.17M.
  • Myriad Asset Management first reported a position in Moderna in Q4 2018 and held it in 7 quarters.
  • Myriad Asset Management's Moderna position peaked at $71.2M in Q2 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Myriad Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.